Primary cutaneous lymphomas: A review with current treatment options

Christiane Querfeld, Joan Guitart, Timothy M. Kuzel, Steven T. Rosen*

*Corresponding author for this work

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Primary cutaneous T- and B-cell lymphomas are a heterogenous group of diseases with varied clinical presentations and prognosis. The use of new molecular, histological, and clinical criteria have enhanced the recognition of primary cutaneous T- and B-cell lymphomas. Compared to their nodal counterpart they have a different clinical behavior and therefore require a different treatment approach. Independent predictive factors identified clinically, histologically, and by immunopheno- and immunogenotyping are essential to assess the appropriate treatment for each subtype. The European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Study Group provide a classification of cutaneous lymphomas taking into account of the histological and molecular features. Based on this classification we will provide a summary of the current medical literature in diagnosis, treatment, and prognosis for primary cutaneous lymphomas with emphasis on new treatment strategies.

Original languageEnglish (US)
Pages (from-to)131-142
Number of pages12
JournalBlood Reviews
Volume17
Issue number3
DOIs
StatePublished - Jan 1 2003

Fingerprint

Cutaneous T-Cell Lymphoma
Lymphoma
B-Cell Lymphoma
Skin
Skin Neoplasms
Research

Keywords

  • Clinicopathologic correlations
  • Primary cutaneous lymphoma
  • Prognostic indices
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Querfeld, Christiane ; Guitart, Joan ; Kuzel, Timothy M. ; Rosen, Steven T. / Primary cutaneous lymphomas : A review with current treatment options. In: Blood Reviews. 2003 ; Vol. 17, No. 3. pp. 131-142.
@article{8a4202c972a240dabd81a1fe63645622,
title = "Primary cutaneous lymphomas: A review with current treatment options",
abstract = "Primary cutaneous T- and B-cell lymphomas are a heterogenous group of diseases with varied clinical presentations and prognosis. The use of new molecular, histological, and clinical criteria have enhanced the recognition of primary cutaneous T- and B-cell lymphomas. Compared to their nodal counterpart they have a different clinical behavior and therefore require a different treatment approach. Independent predictive factors identified clinically, histologically, and by immunopheno- and immunogenotyping are essential to assess the appropriate treatment for each subtype. The European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Study Group provide a classification of cutaneous lymphomas taking into account of the histological and molecular features. Based on this classification we will provide a summary of the current medical literature in diagnosis, treatment, and prognosis for primary cutaneous lymphomas with emphasis on new treatment strategies.",
keywords = "Clinicopathologic correlations, Primary cutaneous lymphoma, Prognostic indices, Treatment",
author = "Christiane Querfeld and Joan Guitart and Kuzel, {Timothy M.} and Rosen, {Steven T.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0268-960X(03)00004-3",
language = "English (US)",
volume = "17",
pages = "131--142",
journal = "Blood Reviews",
issn = "0268-960X",
publisher = "Churchill Livingstone",
number = "3",

}

Primary cutaneous lymphomas : A review with current treatment options. / Querfeld, Christiane; Guitart, Joan; Kuzel, Timothy M.; Rosen, Steven T.

In: Blood Reviews, Vol. 17, No. 3, 01.01.2003, p. 131-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Primary cutaneous lymphomas

T2 - A review with current treatment options

AU - Querfeld, Christiane

AU - Guitart, Joan

AU - Kuzel, Timothy M.

AU - Rosen, Steven T.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Primary cutaneous T- and B-cell lymphomas are a heterogenous group of diseases with varied clinical presentations and prognosis. The use of new molecular, histological, and clinical criteria have enhanced the recognition of primary cutaneous T- and B-cell lymphomas. Compared to their nodal counterpart they have a different clinical behavior and therefore require a different treatment approach. Independent predictive factors identified clinically, histologically, and by immunopheno- and immunogenotyping are essential to assess the appropriate treatment for each subtype. The European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Study Group provide a classification of cutaneous lymphomas taking into account of the histological and molecular features. Based on this classification we will provide a summary of the current medical literature in diagnosis, treatment, and prognosis for primary cutaneous lymphomas with emphasis on new treatment strategies.

AB - Primary cutaneous T- and B-cell lymphomas are a heterogenous group of diseases with varied clinical presentations and prognosis. The use of new molecular, histological, and clinical criteria have enhanced the recognition of primary cutaneous T- and B-cell lymphomas. Compared to their nodal counterpart they have a different clinical behavior and therefore require a different treatment approach. Independent predictive factors identified clinically, histologically, and by immunopheno- and immunogenotyping are essential to assess the appropriate treatment for each subtype. The European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Study Group provide a classification of cutaneous lymphomas taking into account of the histological and molecular features. Based on this classification we will provide a summary of the current medical literature in diagnosis, treatment, and prognosis for primary cutaneous lymphomas with emphasis on new treatment strategies.

KW - Clinicopathologic correlations

KW - Primary cutaneous lymphoma

KW - Prognostic indices

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0037699296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037699296&partnerID=8YFLogxK

U2 - 10.1016/S0268-960X(03)00004-3

DO - 10.1016/S0268-960X(03)00004-3

M3 - Article

C2 - 12818223

AN - SCOPUS:0037699296

VL - 17

SP - 131

EP - 142

JO - Blood Reviews

JF - Blood Reviews

SN - 0268-960X

IS - 3

ER -